Development code · Small Molecule
CVL-562
CVL-562 is a development code for PF-06412562 (CVL-562), developed by Pfizer Inc..
- Status
- Phase 2 for Schizophrenia
- Mechanism
- D1 Partial agonist
- Developer
- Pfizer Inc.
Programs
- PF-06412562 (CVL-562) for SchizophreniaPhase 2Unknown
Also known as
- PF-06412562
- 4-[4-(4,6-dimethylpyrimidin-5-yl)-3-methylphenoxy]-1H-pyrazolo[4,3-c]pyridine
- PF 06412562
- PF2562
- 1609258-91-4